Navigenics Adds Genetic Drug Response Results to Service; Offers PGx Wallet Card

Navigenics has added a new medications feature to its service offerings and is providing customers with a wallet-sized report that contains a condensed version of the genetic response to as many as 12 prescription drugs, which the company began reporting as part of its DTC service this week.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.